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INTRODUCTION
Laparoscopic colon surgery (LAC) was first introduced 
for the treatment of colorectal cancer in 1991 [1]. Since its 
introduction, there have been many technical improvements 
to this procedure. Several randomized controlled trials have 
demonstrated its safety, oncologic efficacy and short-term 
benefits including shorter hospital stays, less postoperative 
pain and earlier return to normal activity compared to an open 
colectomy (OC) [2-11].
Given the technical difficulty involved in performing 
complete mesocolic excision and ligation of the middle colic 
vessels by laparoscopy, many of these trials have not included 
patients with transverse colon cancer [12,13]. Recently, several 
experienced surgeons have started to report on the oncologic 
outcomes for laparoscopic colectomy in patients with transverse 
colon cancer [11,14-16], but long-term outcomes still need to be 
verified.
As a tertiary referral care center, our institution has many 
experiences with laparoscopic surgery for transverse colon 
cancer. This study investigated the oncologic outcomes for 
laparoscopic surgery compared to open surgery in patients with 
transverse colon cancer in our institution.
Purpose: Laparoscopic resection for transverse colon cancer is a technically challenging procedure that has been 
excluded from various large randomized controlled trials of which the long-term outcomes still need to be verified. The 
purpose of this study was to evaluate long-term oncologic outcomes for transverse colon cancer patients undergoing 
laparoscopic colectomy (LAC) or open colectomy (OC).
Methods: This retrospective review included patients with transverse colon cancer who received a colectomy between 
January 2006 and December 2010. Short-term and five-year oncologic outcomes were compared between these groups.
Results: A total of 131 patients were analyzed in the final study (LAC, 84 patients; OC, 47 patients). There were no 
significant differences in age, gender, body mass index, tumor location, operative procedure, or blood loss between 
groups, but the mean operative time in LAC was significantly longer (LAC, 246.8 minutes vs. OC, 213.8 minutes; P = 0.03). 
Hospital stay was much shorter for LAC than OC (9.1 days vs. 14.5 days, P < 0.01). Postoperative complication rates were 
not statistically different between the two groups. In terms of long-term oncologic data, the 5-year disease-free survival 
and overall survival were not statistically different between both groups, and subgroup analysis according to cancer stage 
also revealed no differences. 
Conclusion: LAC for transverse colon cancer is feasible and safe with comparable short- and long-term outcomes.
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METHODS
This retrospective study included 141 consecutive patients 
who underwent a curative colectomy for transverse colon 
cancer (pathologic TNM stage I-III) at the Yonsei University 
Health System between January 2006 and December 2010. Then 
10 patients were excluded due to a previous malignancy, double 
primary cancer and missing follow-up (Fig. 1). 
Diagnosis of colon cancer was confirmed by a colonoscopic 
biopsy. For evaluation of distant metastasis, an abdominopelvic 
and a chest computed tomography (CT) were performed. If 
necessary, a positron emission tomography (PET)-CT and liver 
magnetic resonance imaging (MRI) were also performed. Any 
tumor distal to the hepatic flexure and proximal to the splenic 
flexure was defined as transverse colon cancer. 
Tumor staging was based on the 7th American 
Joint Committee on Cancer guidelines.
The decision to perform a laparoscopic colectomy versus an 
OC was at the surgeon’s discretion. In cases of early transverse 
colon cancer detection, unless the tumor was greater than T3 or 
proved to be bulky on the CT scan, colonoscopic tattooing was 
performed preoperatively for easier intraoperative localization. 
For primary lesions distal to the hepatic flexure, an extended 
right hemicolectomy was performed by ligation of the ileocolic, 
the midcolic and the right colic vessels (if present). Lesions 
proximal to the splenic flexure underwent an extended left 
hemicolectomy with ligation of the midcolic, left colic and 
the first branch of the sigmoid vessels. Transverse colectomy 
was performed by ligation of the midcolic vessels when the 
remaining transverse colon was free enough of tension to 
be anastomosed. Subtotal colectomy was also performed if 
it was necessary. We utilized a medial to lateral no-touch 
isolation technique, which enabled dissection of lymph nodes 
along the surgical trunk, followed by transection of the colon 
and mesentery without tumor manipulation. This degree of 
resection was similar to the technique used in Hohenberger 
et al. [17]. Methods for anastomosis were determined based 
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Table 1. Clinical characteristics and surgical data in the laparoscopic and conventional open surgery groups
Characteristic LAC (n = 84) OC (n = 47) P­value
Age (yr) 62.3 ± 11.6 59.7 ± 13.2 0.24
Sex (male:female) 45:39 27:20 0.67
Body mass index (kg/m2) 23.6 ± 3.7 22.5 ± 3.3 0.12
Location of tumor 0.17
   Hepatic flexure 56 (66.7) 24 (51.1)
   Mid transverse 12 (14.3) 12 (25.5)
   Splenic flexure 16 (19.0) 11 (23.4)
Operation 0.09
   Extended right colectomy 57 (67.9) 24 (51.0)
   Transverse colectomy 11 (13.1) 10 (21.3)
   Extended left colectomy 16 (19.0) 11 (23.4)
   Subtotal colectomy 0 (0) 2 (4.3)
Operation time (min) 246.8 ± 85.6 213.8 ± 72.8 0.03
Blood loss (mL) 125.8 ± 224.5 130.0 ± 161.6 0.91
Conversion to open 2 (2.4) ­ ­
Values are presented as mean ± standard deviation or number (%). An independent t­test for continuous values and chi­square test for 
categorical values. 
LAC, laparoscopic colectomy; OC, open colectomy.
Fig. 1. Overall study design and 
overview of patient population.
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on surgical preference and performed extracorporially in 
laparoscopic colectomy cases in a manner similar to the open 
procedure.
Clinical characteristics, short-term surgical outcomes 
and midterm oncologic outcomes were compared between 
the laparoscopic and open surgery groups. Postoperative 
Table 2. Tumor characteristics in the laparoscopic and conventional open surgery groups
Characteristic LAC (n = 84) OC (n = 47) P­value
Tumor size (cm) 4.6 ± 2.7 5.0 ± 2.5 0.37
Grade of differentiation 0.34
   Well 19 (22.6) 8 (17.1)
   Moderately 54 (64.3) 34 (72.3)
   Poorly 7 (8.3) 1 (2.1)
   Others 4 (4.8) 4 (8.5)
PRM (cm) 20.7 ± 13.7 22.7 ± 15.1 0.45
DRM (cm) 10.9 ± 10.5 12.8 ± 10.3 0.31
No. of retrieved lymph nodes 27.4 ± 21.7 28.0 ± 19.8 0.88
pTNM stage 0.01
   Tis / I 28 (33.3) 6 (12.7)
   II 37 (44.0) 21 (44.7)
   III 19 (22.6) 20 (42.6)
Values are presented as mean ± standard deviation or number (%). An independent t­test for continuous values and chi­square test for 
categorical values. 
LAC, laparoscopic colectomy; OC, open colectomy; PRM, proximal resection margin; DRM, distal resection margin.
Table 3. Postoperative short­term outcomes in the laparoscopic and conventional open surgery groups
Characteristic LAC (n = 84) OC (n = 47) P­value
Hospital stay (day) 9.1 ± 4.4 14.5 ± 7.5 <0.01
Morbidity 0.16
   Minor complication, n (%) 7 (8.4) 6 (12.8)
      Grade I
         Wound seroma 4 0
         Atelectasis 1 0
      Grade II
         Ileus or obstruction 0 2
         Minor bleeding 2 1
         Chylous ascites 0 2
         Pancreatitis 0 1
   Major complication, n (%) 1 (1.2) 2 (4.3)
       Grade III
         Anastomotic leakage 1 2
       Grade IV 0 0
       Grade V      0 0
Recurrence site ­
   Local 2 0
   Systemic 7 6
      Liver 4 3
      Lung 2 3
      Stomach 1 0
      Duodenum 1 1
      Peritoneal seeding 3 1
Values are presented as mean ± standard deviation or number (%). An independent t­test for continuous values and chi­square test for 
categorical values. 
LAC, laparoscopic colectomy; OC, open colectomy.
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complications were classified as grades I-V according to the 
Dindo classification scale, which were further subdivided into 
minor (stages I-II) and major (stages III-V) complications [18]. 
We routinely examined patients in the outpatient clinic at 1 
and 3 months postdischarge, then every 3 months for the first 
three years and finally every 6 months for the subsequent 
2 years. Carcinoembryonic antigen was performed prior to 
surgery, at postoperative day 7 and whenever the patient had 
postoperative follow-up in the outpatient clinic. For diagnosis 
of local and systemic recurrence, an abdominopelvic CT and a 
chest CT were performed at every 6 months during the follow-
up period. A PET-CT and liver MRI were also performed if it was 
necessary. 
Data were analyzed using the IBM SPSS ver. 18.0 (IBM Co., 
Armonk, NY, USA). An independent t-test for continuous values 
and Fisher exact test for parametric values were performed. 
Categorical variables were compared using the chi-square test 
(Tables 1-3). We constructed survival curves using the Kaplan-
Meier method (Figs. 2, 3) and comparisons were made using 
the log-rank test. A P-value less than 0.05 was considered 
statistically significant.
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Fig. 2. Kaplan­Meier estimates of overall survival (A) and disease free survival (B) in the laparoscopic and conventional open 
group for stage II transverse colon cancer. OC, open colectomy; LAC, laparoscopic colectomy.
Fig. 3. Kaplan­Meier estimates of overall survival (A) and disease free survival (B) in the laparoscopic and conventional open 
group for stage III transverse colon cancer. LAC, laparoscopic colectomy; OC, open colectomy. 
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RESULTS
A total of 131 patients were analyzed in the final study 
(LAC, 84 patients; OC, 47 patients). Patient demographics and 
operative data are presented in Table 1. There was no difference 
in sex, age, body mass index, tumor location, operative 
procedure or blood loss between the groups, but the mean 
operative time in LAC was significantly longer (LAC, 246.8 
minutes vs. OC, 213.8 minutes; P = 0.03). Two cases (2.4%) 
were converted to open surgery due to the presence of severe 
adhesions. 
There were no significant differences in tumor size, histo-
logy type between the two groups (Table 2). No intergroup 
differences in proximal margin, distal margin and number of 
harvested lymph nodes were also observed. According to the 
TNM classification system, early stage transverse colon cancer 
(Tis, stage I) was observed more frequently in the LAC group 
compared to the OC group (33.3% vs. 12.7%), whereas stage 
III disease was more prevalent in the OC group than the LAC 
group (42.6% vs. 22.6%) (P = 0.01).
Hospital stay was considerably shorter for LAC than for OC 
(9.1 days vs. 14.5 days, P < 0.01) (Table 3). Rates of postoperative 
complications were not statistically different between the two 
groups (OC, 17.1% vs. LAC, 9.6%, P = 0.16). Most complications 
were minor including wound seroma, postoperative ileus or 
obstruction, minor bleeding and chylous ascites. Regarding 
major complications, two cases of grade 3 complications 
included major anastomotic leakages in the OC group, which 
required mandatory reoperations. One case of a grade 3 
complication included a minor anastomotic leakage in the LAC 
group requiring only supportive care. There were no cases of 
immediate postoperative mortality in the two groups. 
Median follow-up was 58 months (range, 10-85 months) for 
OC and 42 months (range, 7-82 months) for LAC. Nine patients 
(10.7%) had cancer recurrence in the LAC group during the 
follow-up period. Four patients died from systemic recurrence 
and cancer progression. In the OC group, 6 patients (12.8%) had 
cancer recurrences. Five of them had systemic recurrence and 
died from cancer progression. Five-year disease free survival 
(DFS) was 87.4% for LAC and 85.7% for OC, with no statistically 
significant difference between the two groups (P = 0.89). There 
were no intergroup differences in the 5-year overall survival (OS) 
(LAC, 94.3% vs. OC, 86.7%, P = 0.40). 
We performed a subgroup analysis to evaluate any group 
differences attributable to the discrepancy of the cancer stage. 
According to our data, it was statistically impossible to compare 
DFS and OS in stage I patients between the two groups because 
there were no recurrence or disease-related death except only 
one recurrence in the LAC group. According to a subgroup 
analysis of stage II and III transverse colon cancer patients, 
there were no significant differences in OS and DFS between 
the two groups (Figs. 2, 3). The results demonstrated that there 
were no statistically significant differences in 5-year DFS for 
stage II patients (LAC, 85.5% vs. OC, 100%, P = 0.09). In terms 
of 5-year OS, there were no statistical differences between the 
two groups (LAC, 92.8% vs. OC, 100%, P = 0.24). Similarly, there 
were no differences in 5-year DFS for stage III patients between 
both groups (LAC, 77.6% vs. OC, 68.2%, P = 0.66). 5-year OS in 
stage III patients were similar between two groups (LAC, 88.2% 
vs. OC, 71.2%, P = 0.57).
DISCUSSION
Laparoscopic approaches have been proposed in several 
surgical fields, and these modalities provide widely-recognized 
clinical benefits, including less pain and intraoperative blood 
loss, shorter recovery and hospitalization times, and better 
cosmetics. Laparoscopic colectomy has been shown not only 
to be technically safe and feasible, but also offers similar long-
term outcomes for colorectal cancer compared to open surgical 
procedures based on large, randomized controlled trials [4-
8]. However, all these studies have excluded transverse colon 
cancer due to the technical difficulty in performing an adequate 
oncologic resection laparoscopically, and very few studies are 
available for laparoscopic colectomy of the transverse colon 
cancer.
In our results, LAC for transverse colon cancer was found 
to be quite safe and feasible. The rates of postoperative com-
plications were not statistically different between the LAC and 
OC groups (OC, 17.1% vs. LAC, 9.6%, P = 0.16). These similar 
rates are comparable with other reports. Akiyoshi et al. [19] and 
Kim et al. [20] also reported in their studies that short-term 
postoperative complications were acceptable in laparoscopic 
colectomy for transverse colon cancer. 
Generally, oncologic feasibility can be assessed from three 
points of view. First of all, adequate oncologic resection 
should be evaluated. Secondly, the recurrence rate should 
be acceptable. Lastly, OS should not be influenced by the 
surgical methods. Recently, some studies have started to report 
oncologic outcomes for LAC in transverse colon cancer. Hahn 
et al. [15] reported acceptable oncologic outcomes compared 
to other previous randomized trials. The 5-year OS rate and 
disease-free survival rate was 84.7% and 89.3%, respectively in 
their study. However, the laparoscopic results were compared to 
results of other previous clinical trials instead of the results for 
open surgery results from the same period. On the other hand, 
our study showed acceptable oncologic outcomes of LAC for 
transverse colon cancer compared to OC during the follow-up 
observation. 
In our study, 5-year DFS was 87.4% in LAC and 85.7% in OC 
(P = 0.89), whereas 5-year OS was 94.3% in LAC and 86.7% in 
OC (P = 0.40). These are also comparable oncologic results 
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to others. We suspect that these favorable oncologic results 
can be attributed to the surgical technique and planning. All 
laparoscopic colectomies in this study had complete mesocolic 
excision (CME) and central vascular ligation (CVL), first named 
by Hohenberger et al. [17] in 2008. There have been some 
debates of feasibility for CME-CVL in LAC. Gouvas et al. [21] 
insisted that laparoscopic CME-CVL surgery for transverse colon 
cancer was incomplete in comparison to open surgical resection 
in their study. However, Fujita et al. [22] described a medial 
approach to overcome this obstacle. They utilized a no-touch 
technique, which dissected lymph nodes along the surgical 
trunk, followed by transection of the transverse colon, terminal 
ileum, and mesentery without tumor manipulation. We also 
utilized this medial to lateral no-touch isolation technique. We 
also reported no significant differences in proximal resection 
margin (LAC, 20.7 cm vs. OC, 22.7 cm, P = 0.45), distal resection 
margin (LAC, 10.9 cm vs. OC, 12.8 cm, P = 0.31), and harvested 
lymph nodes (LAC, 27.4 vs. OC, 28.0, P = 0.88) between the LAC 
and OC groups. Therefore, we can confirm that laparoscopic 
transverse colectomy could be oncologically feasible for 
transverse colon cancer compared to open surgery.
This study does have some limitations. First, there was 
the selection bias often inherent in retrospective studies. 
The decision to undergo a laparoscopic colectomy was at the 
surgeon’s discretion. Early stage transverse colon cancer (stages 
0, I) more frequently proceeded to laparoscopic resection 
(LAC, 33.3% vs. OC, 12.7%). Meanwhile, advanced transverse 
colon cancer (stage III) was more frequently associated with 
open surgery (OC, 42.6% vs. LAC, 22.6%). For this reason, we 
performed a subgroup analysis for each stage, and similar 
results for the long-term follow-up between the two groups 
were also shown in the subgroup analysis. The second imitation 
is the small number of cases. 
Based on the results of this study, laparoscopic colectomy for 
transverse colon cancer was feasible and safe with good short-
term outcomes. Moreover, there were no significant differences 
in long-term oncologic outcomes between laparoscopy and open 
surgery. However, our conclusion cannot be generalized because 
of our study limitation. Nevertheless, we expect that our 
study may help lead to conduct future prospective randomized 
trials for investigation of long-term oncologic outcomes for 
laparoscopic colectomy in transverse colon cancer to confirm 
our study results. 
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